User:Tkadm30/Notebook/Drospirenone: Difference between revisions
From OpenWetWare
< User:Tkadm30 | Notebook
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
* optical isomerism (C2) : a HSL (homoserine) lactone derivative ? | * optical isomerism (C2) : a HSL (homoserine) lactone derivative ? | ||
* A high risks of hyperkalemia (K+) was found with long-term use of Yasmin. [http://sante.canoe.ca/drug_info_details.asp?brand_name_id=2052 2] | * A high risks of hyperkalemia (K+) was found with long-term use of Yasmin. [http://sante.canoe.ca/drug_info_details.asp?brand_name_id=2052 2] | ||
* Ethics of birth control with chiral | * Ethics of birth control with chiral Schiff base alkyloids in orthogonal Fmoc-carbonyl nucleophilic catalysis? See [http://en.wikipedia.org/wiki/Grignard_reagent Grignard reagent] . | ||
* Hence, is there a Yb(OTf)3 (distereoselective) route to remote activation of Fmoc-protected alkylamines via MW catalysis of C(2)-symmetric amines, ie Drospirenone ? See http://www.organic-chemistry.org/abstracts/literature/979.shtm | |||
== References == | == References == | ||
Line 8: | Line 11: | ||
# http://en.wikipedia.org/wiki/Drospirenone | # http://en.wikipedia.org/wiki/Drospirenone | ||
# http://en.wikipedia.org/wiki/Spironolactone | # http://en.wikipedia.org/wiki/Spironolactone | ||
== See also == | |||
[[Pyrrolidines]] |
Revision as of 08:45, 4 February 2013
- CYP450 mediated [1] (A spironolactone derived alkyloid)
- optical isomerism (C2) : a HSL (homoserine) lactone derivative ?
- A high risks of hyperkalemia (K+) was found with long-term use of Yasmin. 2
- Ethics of birth control with chiral Schiff base alkyloids in orthogonal Fmoc-carbonyl nucleophilic catalysis? See Grignard reagent .
- Hence, is there a Yb(OTf)3 (distereoselective) route to remote activation of Fmoc-protected alkylamines via MW catalysis of C(2)-symmetric amines, ie Drospirenone ? See http://www.organic-chemistry.org/abstracts/literature/979.shtm